RESUMO
OBJECTIVES: Trypanosoma cruzi reactivation in HIV patients is considered an opportunistic infection, usually with a fatal outcome. The aim of this study was to describe the epidemiological and clinical features of T. cruzi infection in HIV patients and to compare these findings between patients with and without Chagas disease reactivation. METHODS: The medical records of T. cruzi-HIV co-infected patients treated at the Muñiz Infectious Diseases Hospital from January 2005 to December 2014 were reviewed retrospectively. Epidemiological and clinical features were assessed and compared between patients with and without Chagas disease reactivation. RESULTS: The medical records of 80 T. cruzi-HIV co-infected patients were reviewed. The most likely route of T. cruzi infection was vector-borne (32/80 patients), followed by intravenous drug use (12/80). Nine of 80 patients had reactivation. Patients without reactivation had a significantly higher CD4 T-cell count at diagnosis of T. cruzi infection (144 cells/µl vs. 30 cells/µl, p=0.026). Chagas disease serology was negative in two of nine patients with reactivation. CONCLUSIONS: Serological assays for T. cruzi infection may be negative in severely immunocompromised patients. Direct parasitological techniques should be performed in the diagnosis of patients for whom there is a suspicion of T. cruzi reactivation. HIV patients with a lower CD4 count are at higher risk of reactivation.
Assuntos
Síndrome da Imunodeficiência Adquirida/virologia , Doença de Chagas/parasitologia , Infecções Oportunistas/parasitologia , Trypanosoma cruzi/fisiologia , Síndrome da Imunodeficiência Adquirida/complicações , Síndrome da Imunodeficiência Adquirida/epidemiologia , Adulto , Argentina/epidemiologia , Linfócitos T CD4-Positivos/imunologia , Doença de Chagas/diagnóstico , Doença de Chagas/etiologia , Feminino , Infecções por HIV/complicações , Infecções por HIV/imunologia , Infecções por HIV/virologia , Humanos , Hospedeiro Imunocomprometido , Masculino , Pessoa de Meia-Idade , Infecções Oportunistas/epidemiologia , Infecções Oportunistas/etiologia , Estudos Retrospectivos , Trypanosoma cruzi/isolamento & purificação , Adulto JovemAssuntos
Doença de Chagas/transmissão , Coinfecção/transmissão , Infecções por HIV/transmissão , Transmissão Vertical de Doenças Infecciosas , Argentina , Evolução Fatal , Feminino , Infecções por HIV/tratamento farmacológico , Humanos , Lactente , Masculino , Gravidez , Complicações Infecciosas na Gravidez/tratamento farmacológicoRESUMO
BACKGROUND: Genetic characterization of HIV-1 in Argentina has shown that BF recombinants predominate among heterosexuals and injecting drug users, while in men who have sex with men the most prevalent form is subtype B. OBJECTIVES: The aim of this work was to investigate the presence of HIV dual infections in HIV-infected individuals with high probability of reinfection STUDY DESIGN: Blood samples were collected from 23 HIV positive patients with the risk of reinfection from Buenos Aires. A fragment of the HIV gene pol was amplified and phylogenetic analyses were performed. Antiretroviral drug resistance patterns of all the sequences were analyzed. RESULTS: Five dual infections were detected with four patients coinfected with subtype B and BF recombinants and one patient was coinfected with two BF recombinants presenting different recombination patterns. Prolonged infection with a stable clinical condition was observed in the five individuals. Resistance mutation patterns were different between the predominant and the minority strains. CONCLUSIONS: Our results show that HIV dual infection can occur with closely related subtypes, and even with different variants of the same recombinant form in certain populations. Clinical observations showed neither aggressive disease progression nor impact on the resistance patterns in the dually-infected patients.
Assuntos
Infecções por HIV/tratamento farmacológico , Infecções por HIV/virologia , HIV-1/classificação , HIV-1/isolamento & purificação , Fármacos Anti-HIV/farmacologia , Argentina , Sangue/virologia , Análise por Conglomerados , Farmacorresistência Viral , HIV-1/genética , Humanos , Masculino , Mutação de Sentido Incorreto , Filogenia , Reação em Cadeia da Polimerase , Análise de Sequência de DNA , Produtos do Gene pol do Vírus da Imunodeficiência Humana/genéticaRESUMO
To analyze humoral cross-reactivity to V3 peptides from subtype B and BF recombinant forms, plasma samples from 50 HIV-1-infected patients were characterized by sequencing fragments of the env and pol genes. An in-house EIA was performed using peptides corresponding to the 15 central amino acids of the V3 loop of gp120 from subtypes B (MN, SF2) and F1 and a consensus peptide from Argentinean BF recombinants. No differences were found with respect to the infecting subtype, but significant differences were found among the peptides. Reactivity was higher against the MN and BF peptides in both groups infected with subtype B (n = 28) and BF (n = 22) recombinants than against subtype F1 and SF2 peptides.
Assuntos
Anticorpos Anti-HIV/sangue , Infecções por HIV/imunologia , Infecções por HIV/virologia , HIV-1/imunologia , Produtos do Gene env do Vírus da Imunodeficiência Humana , Adolescente , Adulto , Argentina , Criança , Pré-Escolar , Análise por Conglomerados , Reações Cruzadas , Feminino , Humanos , Técnicas Imunoenzimáticas/métodos , Lactente , Masculino , Pessoa de Meia-Idade , Filogenia , Análise de Sequência de DNA , Homologia de Sequência , Soro/imunologia , Adulto Jovem , Produtos do Gene env do Vírus da Imunodeficiência Humana/genética , Produtos do Gene env do Vírus da Imunodeficiência Humana/imunologia , Produtos do Gene pol do Vírus da Imunodeficiência Humana/genéticaRESUMO
BACKGROUND: Cells of monocyte/macrophage lineage are one of the major targets of HIV-1 infection and serve as reservoirs for viral persistence in vivo. These cells are also the target of the protozoa Trypanosoma cruzi, the causative agent of Chagas disease, being one of the most important endemic protozoonoses in Latin America. It has been demonstrated in vitro that co-infection with other pathogens can modulate HIV replication. However, no studies at cellular level have suggested an interaction between T. cruzi and HIV-1 to date. METHODOLOGY/PRINCIPAL FINDINGS: By using a fully replicative wild-type virus, our study showed that T. cruzi inhibits HIV-1 antigen production by nearly 100% (p<0.001) in monocyte-derived macrophages (MDM). In different infection schemes with luciferase-reporter VSV-G or BaL pseudotyped HIV-1 and trypomastigotes, T. cruzi induced a significant reduction of luciferase level for both pseudotypes in all the infection schemes (p<0.001), T. cruzi-HIV (>99%) being stronger than HIV-T. cruzi (approximately 90% for BaL and approximately 85% for VSV-G) infection. In MDM with established HIV-1 infection, T. cruzi significantly inhibited luciferate activity (p<0.01). By quantifying R-U5 and U5-gag transcripts by real time PCR, our study showed the expression of both transcripts significantly diminished in the presence of trypomastigotes (p<0.05). Thus, T. cruzi inhibits viral post-integration steps, early post-entry steps and entry into MDM. Trypomastigotes also caused a approximately 60-70% decrease of surface CCR5 expression on MDM. Multiplication of T. cruzi inside the MDM does not seem to be required for inhibiting HIV-1 replication since soluble factors secreted by trypomastigotes have shown similar effects. Moreover, the major parasite antigen cruzipain, which is secreted by the trypomastigote form, was able to inhibit viral production in MDM over 90% (p<0.01). CONCLUSIONS/SIGNIFICANCE: Our study showed that T. cruzi inhibits HIV-1 replication at several replication stages in macrophages, a major cell target for both pathogens.
Assuntos
HIV-1/fisiologia , Macrófagos/parasitologia , Macrófagos/virologia , Monócitos/citologia , Parasitos/fisiologia , Trypanosoma cruzi/fisiologia , Replicação Viral/fisiologia , Animais , Antígenos de Protozoários/metabolismo , Antígenos CD4/metabolismo , Cisteína Endopeptidases/metabolismo , Humanos , Camundongos , Especificidade de Órgãos , Parasitos/imunologia , Proteínas de Protozoários , Receptores CCR5/metabolismo , Solubilidade , Trypanosoma cruzi/imunologia , Montagem de Vírus/fisiologia , Integração Viral/fisiologia , Internalização do VírusAssuntos
Vírus da Influenza A/genética , Vírus da Influenza A/patogenicidade , Vírus da Influenza A Subtipo H1N1/genética , Vírus da Influenza A/ultraestrutura , Dados de Sequência Molecular , Influenza Humana/diagnóstico , Influenza Humana/virologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Cultura de Vírus , Técnica Indireta de Fluorescência para AnticorpoAssuntos
Vírus da Influenza A Subtipo H1N1/genética , Vírus da Influenza A/genética , Vírus da Influenza A/patogenicidade , Cultura de Vírus , Dados de Sequência Molecular , Influenza Humana/diagnóstico , Influenza Humana/virologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Técnica Indireta de Fluorescência para Anticorpo , Vírus da Influenza A/ultraestruturaRESUMO
BACKGROUND: Several factors determine the risk of HIV mother-to-child transmission (MTCT), such as coinfections in placentas from HIV-1 positive mothers with other pathogens. Chagas' disease is one of the most endemic zoonoses in Latin America, caused by the protozoan Trypanosoma cruzi. The purpose of the study was to determine whether T. cruzi modifies HIV infection of the placenta at the tissue or cellular level. RESULTS: Simple and double infections were carried out on a placental histoculture system (chorionic villi isolated from term placentas from HIV and Chagas negative mothers) and on the choriocarcinoma BeWo cell line. Trypomastigotes of T. cruzi (VD lethal strain), either purified from mouse blood or from Vero cell cultures, 24 h-supernatants of blood and cellular trypomastigotes, and the VSV-G pseudotyped HIV-1 reporter virus were used for the coinfections. Viral transduction was evaluated by quantification of luciferase activity. Coinfection with whole trypomastigotes, either from mouse blood or from cell cultures, decreased viral pseudotype luciferase activity in placental histocultures. Similar results were obtained from BeWo cells. Supernatants of stimulated histocultures were used for the simultaneous determination of 29 cytokines and chemokines with the Luminex technology. In histocultures infected with trypomastigotes, as well as in coinfected tissues, IL-6, IL-8, IP-10 and MCP-1 production was significantly lower than in controls or HIV-1 transducted tissue. A similar decrease was observed in histocultures treated with 24 h-supernatants of blood trypomastigotes, but not in coinfected tissues. CONCLUSION: Our results demonstrated that the presence of an intracellular pathogen, such as T. cruzi, is able to impair HIV-1 transduction in an in vitro system of human placental histoculture. Direct effects of the parasite on cellular structures as well as on cellular/viral proteins essential for HIV-1 replication might influence viral transduction in this model. Nonetheless, additional mechanisms including modulation of cytokines/chemokines at placental level could not be excluded in the inhibition observed. Further experiments need to be conducted in order to elucidate the mechanism(s) involved in this phenomenon. Therefore, coinfection with T. cruzi may have a deleterious effect on HIV-1 transduction and thus could play an important role in viral outcome at the placental level.
Assuntos
Doença de Chagas/virologia , Vilosidades Coriônicas/virologia , HIV-1/fisiologia , Trypanosoma cruzi/fisiologia , Animais , Linhagem Celular , Doença de Chagas/patologia , Doença de Chagas/fisiopatologia , Vilosidades Coriônicas/anatomia & histologia , Vilosidades Coriônicas/metabolismo , Feminino , HIV-1/metabolismo , HIV-1/patogenicidade , Humanos , Placenta/imunologia , Placenta/virologia , Replicação Viral/efeitos dos fármacosRESUMO
The aim of this study was to estimate the seroprevalence rates of human immunodeficiency virus (HIV), hepatitis B virus (HBV, core antibody), hepatitis C virus (HCV), and syphilis infections and analyze associated risk factors among 504 non-injecting cocaine users (NICU) in Buenos Aires, Argentina. Participants were interviewed in face-to-face sessions through a short structured questionnaire. Using venipuncture, 10 mL of blood was collected. Seroprevalence rates were: HIV (6.3%), HBV (9%), HCV (7.5%), and VDRL (4.2%). The risk of being infected with HIV, HBV, and HCV was significantly associated with having had a sex partner who was either a drug injector or who was known to be HIV positive. HIV and HCV infections were associated with former imprisonment, and HCV was associated with having been tattooed. Because of the rising number of NICU and the multiple infections detected, it is essential to implement prevention strategies focused on this population.
Assuntos
Transtornos Relacionados ao Uso de Cocaína/epidemiologia , Infecções por HIV/epidemiologia , Hepatite B/epidemiologia , Hepatite C/epidemiologia , Sífilis/epidemiologia , Adolescente , Adulto , Idoso , Análise de Variância , Argentina/epidemiologia , Transtornos Relacionados ao Uso de Cocaína/complicações , Estudos Transversais , Feminino , Infecções por HIV/sangue , Infecções por HIV/etiologia , Hepatite B/sangue , Hepatite B/etiologia , Hepatite C/sangue , Hepatite C/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Fatores de Risco , Estudos Soroepidemiológicos , Parceiros Sexuais , Fatores Socioeconômicos , Abuso de Substâncias por Via Intravenosa/complicações , Sífilis/sangue , Sífilis/etiologia , Tatuagem/efeitos adversosRESUMO
El propósito de este estudio era estimar los índices de seroprevalencia del virus de inmunodeficiencia humano (VIH), virus de la hepatitis B (VHB, anticuerpo core), virus de la hepatitis C (VHC) e infecciones de sífilis y analizar factores de riesgo asociados entre 504 usuarios de cocaína no inyectable (UCNI) en la ciudad de Buenos Aires, Argentina. Se entrevistó a los participantes en sesiones cara a cara a través de un cuestionario estructurado corto. Usando el método de la venipunción se recogieron 10mL de sangre. Las tasas de seroprevalencia fueron: VIH (6,3 por ciento), VHB (9 por ciento), VHC (7,5 por ciento), y VDRL (4,2 por ciento). El riesgo de infección por VIH, VHB, y VHC se asoció significativamente a mantener relaciones sexuales con un compañero/a que era consumidor de la droga inyectada o que era conocido por ser VIH positivo. Las infecciones de VIH y de VHC se asociaron a haber estado encarcelado anteriormente, y la de VHC se asoció también a haber sido tatuado. Debido al número creciente de UCNI y a las infecciones múltiples detectadas, es esencial implementar estrategias de prevención centradas en esta población.
The aim of this study was to estimate the seroprevalence rates of human immunodeficiency virus (HIV), hepatitis B virus (HBV, core antibody), hepatitis C virus (HCV), and syphilis infections and analyze associated risk factors among 504 non-injecting cocaine users (NICU) in Buenos Aires, Argentina. Participants were interviewed in face-to-face sessions through a short structured questionnaire. Using venipuncture, 10mL of blood was collected. Seroprevalence rates were: HIV (6.3 percent), HBV (9 percent), HCV (7.5 percent), and VDRL (4.2 percent). The risk of being infected with HIV, HBV, and HCV was significantly associated with having had a sex partner who was either a drug injector or who was known to be HIV positive. HIV and HCV infections were associated with former imprisonment, and HCV was associated with having been tattooed. Because of the rising number of NICU and the multiple infections detected, it is essential to implement prevention strategies focused on this population.
Assuntos
Abuso de Substâncias por Via Intravenosa/complicações , Cocaína , Vírus da Hepatite B , Infecções por HIV , Hepatite C/virologia , Drogas Ilícitas , Argentina , Fatores de RiscoRESUMO
BACKGROUND: HIV triggers the decline of CD4+ T cells and leads to progressive dysfunction of cell-mediated immunity. Although an increased susceptibility to cell death occurs during the acute phase of HIV infection, persistently-infected macrophages and quiescent T-cells seem to be resistant to cell death, representing a potential reservoir for virus production. RESULTS: Lymphoid (H9/HTLVIIIB and J1.1) and pro-monocytic (U1) HIV-1 persistently-infected cell lines were treated with hydrogen peroxide (H2O2) and staurosporine (STS) for 24 h, and susceptibility to apoptosis was evaluated and compared with uninfected counterparts (H9, Jurkat and U937 respectively). When exposed to different pro-apoptotic stimuli, all persistently-infected cell lines showed a dramatic reduction in the frequency of apoptotic cells in comparison with uninfected cells. This effect was independent of the magnitude of viral replication, since the induction of viral production in lymphoid or pro-monocytic cells by exposure to TNF-alpha or PMA did not significantly change their susceptibility to H2O2- or STS-induced cell death. A mechanistic analysis revealed significant diferences in mitochondrial membrane potential (MMP) and caspase-3 activation between uninfected and persistently-infected cells. In addition, Western blot assays showed a dramatic reduction of the levels of pro-apototic Bax in mitochondria of persistently-infected cells treated with H2O2 or STS, but not in uninfected cells. CONCLUSION: This study represents the first evidence showing that resistance to apoptosis in persistently-infected lymphoid and monocytic cells is independent of active viral production and involves modulation of the mitochondrial pathway. Understanding this effect is critical to specifically target the persistence of viral reservoirs, and provide insights for future therapeutic strategies in order to promote complete viral eradication.
Assuntos
Apoptose/fisiologia , Infecções por HIV/patologia , Infecções por HIV/virologia , HIV-1/fisiologia , Mitocôndrias/fisiologia , Antivirais/farmacologia , Apoptose/efeitos dos fármacos , Western Blotting , Caspase 3/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Citometria de Fluxo , Humanos , Peróxido de Hidrogênio/farmacologia , Células Jurkat , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/virologia , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Estaurosporina/farmacologia , Linfócitos T/virologia , Células U937 , Replicação Viral , Proteína X Associada a bcl-2/metabolismoRESUMO
The objectives of this study were to estimate the prevalence and characterize the epidemiologic patterns of HTLV-1/2 infections and co-infections with HIV, HBV (hepatitis B), HCV (hepatitis C), and Treponema Pallidum in five different high-risk groups, including injecting drug users (IDUs), female sex workers (FSWs), men who have sex with men (MSM), patients with tuberculosis (TB), and patients attending clinics for sexually transmitted infections (STIs) in Buenos Aires, Argentina. The HTLV-1/2 prevalence was 19.1% (33/173) for IDUs, 2.0% (10/613) for FSWs, 2.1% (4/187) for TB, 1.0% (4/400) for STIs and 0.4% (3/282) for MSM, respectively. Among all groups, the higher percentages of co-infection were HTLV-1/HBV (63%, 17/27) and HTLV-1/HCV (52%, 14/27). Among IDUs, there was a high percentage of co-infection of HTLV-2 with HCV (96.3%, 26/27), HIV (92.6%, 25/27), and HBV (77.8%, 21/27), respectively. In summary, HTLV-1/2 infections appear to be widely distributed among high-risk groups in a nonendemic area of Argentina being the co-infection with HBV and HCV more frequent among IDUs.
Assuntos
Infecções por HTLV-I/epidemiologia , Infecções por HTLV-II/epidemiologia , Vírus Linfotrópico T Tipo 1 Humano/isolamento & purificação , Vírus Linfotrópico T Tipo 2 Humano/isolamento & purificação , Infecções Sexualmente Transmissíveis/complicações , Infecções Sexualmente Transmissíveis/epidemiologia , Adolescente , Adulto , Argentina/epidemiologia , Feminino , Infecções por HIV/complicações , Infecções por HIV/epidemiologia , Infecções por HTLV-I/complicações , Infecções por HTLV-I/virologia , Infecções por HTLV-II/complicações , Infecções por HTLV-II/virologia , Hepatite B/complicações , Hepatite B/epidemiologia , Hepatite C/complicações , Hepatite C/epidemiologia , Homossexualidade Masculina , Vírus Linfotrópico T Tipo 1 Humano/genética , Vírus Linfotrópico T Tipo 2 Humano/genética , Humanos , Masculino , Prevalência , Fatores de Risco , Trabalho Sexual , Abuso de Substâncias por Via Intravenosa , Sífilis/complicações , Sífilis/epidemiologia , Tuberculose/complicações , Tuberculose/epidemiologiaRESUMO
Using the serological testing algorithm for recent HIV seroconversion, we estimated annualized incidences (per 100 person-years) of HIV-1 infection in different at-risk groups in Buenos Aires and Montevideo, during a 5-year period between 1998 and 2003. HIV-positive serum samples from 9 serosurveys conducted among men who have sex with men, patients attending clinics for a sexually transmitted infections consult (STIs), female commercial sex workers, injecting drug users (IDUs), noninjecting cocaine users (NICUs), asymptomatic women screened for HIV infection, and patients with tuberculosis were used. HIV incidences were as follows: 6.7 for men who have sex with men, 2.0 for STIs, 1.3 for female commercial sex workers, 0.0 for Argentinean IDUs, 10.3 for Uruguayan IDUs, 3.1 for Argentinean NICUs, 4.4 for Uruguayan NICUs, and 2.4 for patients with tuberculosis. Among asymptomatic women screened for HIV infection, incidence rose from 0.4 in 1998 to 4.6 in 1999 and to a high of 10.2 in the year 2000. Unexpectedly, high HIV incidences were detected among at-risk groups in Buenos Aires and Montevideo. This pattern shows an emerging HIV epidemic among heterosexuals stemming from core HIV-infected at-risk groups. There is an urgent need for development and implementation of specific prevention strategies to address this burgeoning epidemic.
Assuntos
Algoritmos , Soropositividade para HIV/epidemiologia , Argentina/epidemiologia , Humanos , Técnicas Imunoenzimáticas , Incidência , Uruguai/epidemiologiaRESUMO
Infections with hepatitis C virus, (HCV), hepatitis B virus (HBV), and human T lymphotropic type I/II (HTLV-I/II) virus are commonly found in patients infected with human immunodeficiency virus type 1 (HIV-1). We conducted a seroepidemiologic study among 174 HIV-positive heterosexuals in Buenos Aires, Argentina in 1999. Evidence of exposure to HCV, HBV, and HTLV-I/II was found in 32%, 17%, and 5%, respectively. A higher prevalence of HBV infection was observed among males (33%) compared with females (12%; P < 0.05). Among women, a prior history of a sexually transmitted infection, injecting drug use (IDU), having had more than five lifetime sex partners, and having exchanged sex-for-goods were significantly associated with HCV infection, whereas an IDU history, syringe sharing, and having exchanged sex-for-goods were found to be associated with HBV infection. Among men, an IDU history and syringe/needle sharing were significantly associated with HCV infection. The IDU-related and sexual transmission of hepatitis viruses constitute a significant problem among young, HIV-infected, heterosexuals in Argentina.
Assuntos
Anticorpos Antivirais/sangue , Infecções por HIV/complicações , Infecções por HIV/epidemiologia , Infecções por HTLV-I/epidemiologia , Infecções por HTLV-II/epidemiologia , Hepatite B/epidemiologia , Hepatite C/epidemiologia , Heterossexualidade , Adolescente , Adulto , Argentina/epidemiologia , Estudos Transversais , Feminino , HIV-1/imunologia , Infecções por HTLV-I/complicações , Infecções por HTLV-II/complicações , Hepacivirus/imunologia , Hepatite B/complicações , Vírus da Hepatite B/imunologia , Hepatite C/complicações , Vírus Linfotrópico T Tipo 1 Humano/imunologia , Vírus Linfotrópico T Tipo 2 Humano/imunologia , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco , Estudos SoroepidemiológicosRESUMO
Con el objeto de estudiar las lesiones producidas, por el virus de la coriomeningitis linfocítica (LCMV), se inocularon cobayos adultos por vía intraperitoneal con 1000 UFP de las cepas WE y Armstrong de LCMV. Los animales se scrificaron a los 3, 7,10 y 14 días postinoculación (PI) para estudios de virus en bazo, médula ósea y sangre. En los cobayos infectados con WE se observó destrucción de la pulpa roja esplénica con altos títulos de virus y diferentes grados de neumonitis. Los estudios hematolóficos mostraron linfopenia a partir del día 7 Pl y necrosis focal de la médula ósea. En los animales infectados con la cepa Armstrong sólo se observó una neutropenia moderada sin lesiones evidentes, siendo la replicación del virus menor de 2 log, en relación a WE. La presencia de numerosos polimorfonucleares (PMN) en la pulpa roja esplénica y en el infiltrado pulmonar en forma previa a las lesiones observadas, sugiere que el daño es mediado en alguna forma por esas células. Los cobayos infectados con la cepa WE podrían representar un mdoelo adecuado para estudiar el rol de los PMN en als enfermedades virales, así como los mecanismos patogenéticos no inmunes con respecto a LCMV